JABIL INC.

(JBL)
  Report
Delayed Nyse  -  05/19 04:00:02 pm EDT
57.57 USD   -1.40%
05/18Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Reusable Drug Delivery Device with Broad Applicability
BU
05/17Jabil Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Material and Digital Manufacturing Expansions
BU
05/17Jabil Inc. Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Material and Digital Manufacturing Expansions
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Jabil Healthcare Bray Awarded Shingo Prize for Operational Excellence

10/27/2021 | 08:44am EDT

Jabil Healthcare Bray, a manufacturing site of Jabil Inc. (NYSE: JBL), has been awarded the world’s highest standard for organizational and operational excellence: the Shingo Prize. Awarded by the Shingo Institute, a program in the Jon M. Huntsman School of Business at Utah State University, which recognizes organizations that demonstrate an exceptional culture of continuous improvement, Bray is the first Jabil site to apply for Shingo recognition and becomes one of only 190 organizations globally to receive the Shingo Institute’s highest award.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211027005023/en/

Jabil Healthcare Bray is to receive the world’s highest standard for organizational and operational excellence – the Shingo Prize. (Photo: Business Wire)

Jabil Healthcare Bray is to receive the world’s highest standard for organizational and operational excellence – the Shingo Prize. (Photo: Business Wire)

Jabil Healthcare Bray specializes in the design, development and commercial scale up of complex and innovative healthcare products while also partnering with some of the largest packaging customers in the world. Offering world-class capabilities in design, injection moulding, complex assembly for industrialization and finished pharmaceutical packaging, Jabil Healthcare Bray manufactured more than 1.7 billion products and components in 2019 for the respiratory, ophthalmic, diagnostic, renal health care and packaging markets.

To attain the award, seven Shingo Examiners over four days reviewed the site against the Shingo Model™ and its Guiding Principles. Examiners observed behavior and determined the frequency, duration, intensity and scope of the desired principle-based behavior. They also observed the degree to which leaders focus on principles and culture, and managers focus on aligning systems to drive ideal behaviors at all levels.

“Manufacturing high-quality products have been taking place on this site for over 40 years,” said Jabil Healthcare Bray General Manager Kevin Heffernan. “The Shingo principles have served us well in navigating challenging times, continuously improving and adapting to meet the changing needs of our customers. Shingo enables us to create value and deliver exceptional results for our customers, the world’s largest pharmaceutical, medical device and diagnostic companies.”

“Customers seek out partners who are consistent, reliable and accountable,” said Jabil Healthcare Europe Senior Director of Operations Padhraic McGinn. “Over the last ten years, the Bray site has demonstrated its commitment to continually improve to better serve its customers and that dedication has been formally and externally recognized with the Shingo Prize. Congratulations to the team in Bray on this fantastic achievement.”

Jabil Healthcare Bray will be presented with the Shingo Prize at the 34th Annual Shingo Conference on May 19 & 20, 2022 in Orlando, Florida.

About Jabil:

Jabil (NYSE: JBL) is a manufacturing solutions provider with over 260,000 employees across 100 locations in 30 countries. The world's leading brands rely on Jabil's unmatched breadth and depth of end-market experience, technical and design capabilities, manufacturing know-how, supply chain insights and global product management expertise. Driven by a common purpose, Jabil and its people are committed to making a positive impact on their local community and the environment. Visit www.jabil.com to learn more.

About Jabil Healthcare:

Jabil Healthcare is the industry’s largest, most comprehensive healthcare solutions and capabilities provider, giving our customers access to an array of engineering, design, manufacturing and supply chain solutions across multiple sectors of the healthcare industry. We provide innovation, advanced manufacturing and connected solutions for the world’s leading healthcare brands. Jabil Healthcare in Ireland employs over 600 people across its two, state of the art facilities in Bray, Co. Dublin and Waterford.


© Business Wire 2021
All news about JABIL INC.
05/18Jabil Healthcare Announces the Launch of the Qfinity™ Autoinjector Platform, a Re..
BU
05/17Jabil Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Material..
BU
05/17Jabil Inc. Strengthens Additive Manufacturing Offerings with New PK 5000 Engineered Mat..
CI
05/13JABIL INC. : Ex-dividend day for
FA
05/04JABIL INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements..
AQ
04/27Jabil, Ams OSRAM Develop Lateral Flow Testing Platform
MT
04/27Jabil and ams OSRAM Enable Innovative Lateral Flow Testing Platform
BU
04/27Jabil and ams OSRAM Enable Innovative Lateral Flow Testing Platform
CI
04/21Jabil Keeps Quarterly Dividend at $0.08 a Share, Payable June 2 to Shareholders as of M..
MT
04/21Jabil Declares Quarterly Dividend
BU
More news
Analyst Recommendations on JABIL INC.
More recommendations
Financials (USD)
Sales 2022 32 714 M - -
Net income 2022 949 M - -
Net Debt 2022 1 218 M - -
P/E ratio 2022 9,01x
Yield 2022 0,56%
Capitalization 8 246 M 8 246 M -
EV / Sales 2022 0,29x
EV / Sales 2023 0,27x
Nbr of Employees 238 000
Free-Float 49,5%
Chart JABIL INC.
Duration : Period :
Jabil Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JABIL INC.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 58,39 $
Average target price 81,43 $
Spread / Average Target 39,5%
EPS Revisions
Managers and Directors
Mark T. Mondello Chairman & Chief Executive Officer
Meheryar K. Dastoor Regional Controller-Asia Pacific
May Yap Chief Information Officer & Senior Vice President
John Kraus Senior Director-Operations
Robert L. Katz Executive VP & General Counsel
Sector and Competitors
1st jan.Capi. (M$)
JABIL INC.-17.00%8 246
HON HAI PRECISION INDUSTRY CO., LTD.3.37%49 987
AMPHENOL CORPORATION-22.28%40 588
LUXSHARE PRECISION INDUSTRY CO., LTD.-38.25%31 782
LENS TECHNOLOGY CO., LTD.-56.57%7 267
YAGEO CORPORATION-17.00%7 233